Southern Acids (M) Bhd (XKLS:5134) ROCE %: 15.19% (As of Mar. 2026)


XKLS:5134 Southern Acids (M) Bhd XKLS:5134
73 GF Score
Price RM3.03
GF Value RM2.89
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Southern Acids (M) Bhd ROCE %?

Southern Acids (M) Bhd XKLS:5134 73 ROCE % is 15.19% as of Mar. 2026. GuruFocus rates XKLS:5134 with a GF Score™ of 73/100 and a GF Value™ of RM2.89 (Fairly Valued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Southern Acids (M) Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.19%.

Southern Acids (M) Bhd  (XKLS:5134) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Southern Acids (M) Bhd ROCE % Related Terms

Southern Acids (M) Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Southern Acids (M) Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Southern Acids (M) Bhd ROCE % Chart

Southern Acids (M) Bhd Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.95 8.67 4.85 8.10 8.32

Southern Acids (M) Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.10 3.79 8.03 6.67 15.19
XKLS:5134
73GF Score
Southern Acids (M) Bhd XKLS:5134
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Southern Acids (M) Bhd ROCE % Calculation

Southern Acids (M) Bhd's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=76.717/( ( (1007.905 - 92.727) + (1025.179 - 95.565) )/ 2 )
=76.717/( (915.178+929.614)/ 2 )
=76.717/922.396
=8.32 %

Southern Acids (M) Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=138.94/( ( (992.305 - 93.115) + (1025.179 - 95.565) )/ 2 )
=138.94/( ( 899.19 + 929.614 )/ 2 )
=138.94/914.402
=15.19 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.19% mean?
Southern Acids (M) Bhd (XKLS:5134) has a ROCE % of 15.19% as of Mar. 2026.
Is Southern Acids (M) Bhd's ROCE % too high?
Southern Acids (M) Bhd's current ROCE % is 15.19%. The Conglomerates industry median ROCE % is 6.94. Southern Acids (M) Bhd's value of 15.19% is 119% above this industry median. Overall, Southern Acids (M) Bhd has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's ROCE % compare to HON and MMM?
Southern Acids (M) Bhd's ROCE % of 15.19% can be compared against companies in the Conglomerates industry. The industry median ROCE % is 6.94. Southern Acids (M) Bhd's value of 15.19% is 119% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Conglomerates company?
The median ROCE % among Conglomerates companies is 6.94, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Southern Acids (M) Bhd's current ROCE % of 15.19% is 119% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Conglomerates industry, the median ROCE % is 6.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current ROCE % is 15.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.89, compared to a current price of RM3.03 — trading 4.8% above its estimated fair value. The current ROCE % is 15.19% and 119% above the Conglomerates industry median of 6.94. Southern Acids (M) Bhd's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current ROCE % is 15.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?

Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued. The current stock price of RM3.03 is trading 4.8% above its estimated GF Value™ of RM2.89. GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.

Key valuation signals for XKLS:5134:

  • ROCE %: 15.19%
  • GF Value™: RM2.89 vs. price of RM3.03 (4.8% above fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 119% above the Conglomerates median

No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Southern Acids (M) Bhd Business Description

Address No. 8, Jalan Batu Tiga Lama, Level 29, Centro Tower, Klang, SGR, MYS, 41300
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
73GF Score

Get the complete analysis for XKLS:5134

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.03
Price
RM2.89
GF Value